IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 66 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $81,000 | +72.3% | 61,448 | +141.0% | 0.00% | – |
| Q1 2018 | $47,000 | -89.5% | 25,500 | -85.9% | 0.00% | -100.0% |
| Q1 2017 | $448,000 | +62.9% | 181,222 | -1.3% | 0.00% | – |
| Q4 2016 | $275,000 | -42.0% | 183,608 | -0.8% | 0.00% | -100.0% |
| Q3 2016 | $474,000 | +226.9% | 185,164 | +95.0% | 0.00% | – |
| Q2 2016 | $145,000 | -34.1% | 94,970 | -14.6% | 0.00% | – |
| Q1 2016 | $220,000 | -83.3% | 111,150 | -73.9% | 0.00% | -100.0% |
| Q4 2015 | $1,318,000 | +1810.1% | 426,390 | +1956.9% | 0.00% | – |
| Q3 2015 | $69,000 | -48.1% | 20,730 | -42.4% | 0.00% | – |
| Q2 2015 | $133,000 | -7.6% | 35,982 | -7.4% | 0.00% | – |
| Q1 2015 | $144,000 | +278.9% | 38,853 | +194.3% | 0.00% | – |
| Q2 2014 | $38,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,030,604 | $4,285,000 | 0.70% |
| Virtus ETF Advisers LLC | 180,348 | $381,000 | 0.48% |
| Bain Capital Public Equity Management, LLC | 4,564,744 | $9,632,000 | 0.35% |
| Baker Brothers Advisors | 18,315,802 | $38,646,000 | 0.34% |
| Stanley-Laman Group, Ltd. | 483,773 | $1,021,000 | 0.22% |
| FIRST MIDWEST BANK TRUST DIVISION | 493,689 | $1,042,000 | 0.13% |
| GMT CAPITAL CORP | 3,875,546 | $8,178,000 | 0.08% |
| Vident Investment Advisory, LLC | 640,270 | $1,351,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 307,987 | $650,000 | 0.06% |
| Palo Alto Investors LP | 616,355 | $1,301,000 | 0.06% |